Related Experiment Video
Updated: Sep 4, 2025
Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
Published on: December 15, 2023
Downregulation of Calreticulin and Annexin A2 Expression in Acquired Middle Ear Cholesteatoma by 2-DE Analysis
Ning-Chia Chang1,2, Yu-Jen Wu3,4, Ling-Feng Wang2,5
1Department of Otolaryngology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Background:
Many factors are thought to be associated with the development of cholesteatoma, while the mechanisms of its formation remain unclear. This study aimed to identify the potential mechanisms of the proliferation and growth of cholesteatoma by analysis of the differential expressions of proteins in cholesteatoma and retroauricular skin tissue collected from the same patients.
Methods:
The present study is a retrospective study performed in an academic medical center. Comparative proteomics analyses using two-dimensional gel electrophoresis (2-DE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS), in addition to immunohistochemical analysis, were conducted to identify differentially-expressed proteins in cholesteatoma tissue as compared with retroauricular skin tissue. Western blotting was also employed to verify the expression patterns of the specific proteins identified by 2-DE and to measure the changes in potential modulators related to cholesteatoma proliferation and growth.
Results:
Calreticulin (CRT) and annexin A2 (AnxA2) were identified as being differentially-expressed in cholesteatoma by 2-DE and LC-MS/MS, the results of which were in agreement with the results of immunohistochemical analysis and western blotting. Downregulation of CRT and AnxA2 were observed in cholesteatoma.
Conclusion:
Our data suggests that CRT and AnxA2 downregulation are seen in cholesteatoma compared to retroauricular skin. We speculate that the reduced expression of CRT and the persistent inflammatory response play important roles in the epithelial proliferation of cholesteatoma.
Insights
This study found that calreticulin (CRT) and annexin A2 (AnxA2) proteins are downregulated in cholesteatoma tissue. Reduced CRT expression may contribute to cholesteatoma epithelial proliferation and persistent inflammation.
Area of Science:
- Biochemistry
- Molecular Biology
- Otolaryngology
Background:
- Cholesteatoma development mechanisms are not fully understood.
- Identifying protein expression differences in cholesteatoma is crucial for understanding its growth.
- This study investigates protein expression in cholesteatoma versus normal skin.
Purpose of the Study:
- To identify potential mechanisms driving cholesteatoma proliferation and growth.
- To analyze differential protein expression between cholesteatoma and retroauricular skin.
- To investigate the roles of specific proteins in cholesteatoma pathogenesis.
Main Methods:
- Retrospective study utilizing comparative proteomics.
- Two-dimensional gel electrophoresis (2-DE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) for protein identification.
- Immunohistochemical analysis and Western blotting to verify protein expression patterns.
Main Results:
- Calreticulin (CRT) and annexin A2 (AnxA2) were identified as differentially expressed proteins.
- Downregulation of both CRT and AnxA2 was observed in cholesteatoma tissue compared to retroauricular skin.
- Immunohistochemistry and Western blotting confirmed the downregulation of CRT and AnxA2.
Conclusions:
- CRT and AnxA2 downregulation is a key finding in cholesteatoma.
- Reduced CRT expression, alongside inflammation, likely promotes cholesteatoma epithelial proliferation.
- These findings offer insights into cholesteatoma pathogenesis and potential therapeutic targets.
